Maccura Inventory vs Total Liab Analysis

300463 Stock

14.20 0.17 1.21%

Maccura Biotechnology financial indicator trend analysis is infinitely more than just investigating Maccura Biotechnology recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Maccura Biotechnology is a good investment. Please check the relationship between Maccura Biotechnology Inventory and its Total Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Maccura Biotechnology Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Inventory vs Total Liab

Inventory vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Maccura Biotechnology Inventory account and Total Liab. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Maccura Biotechnology's Inventory and Total Liab is 0.95. Overlapping area represents the amount of variation of Inventory that can explain the historical movement of Total Liab in the same time period over historical financial statements of Maccura Biotechnology Co, assuming nothing else is changed. The correlation between historical values of Maccura Biotechnology's Inventory and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Inventory of Maccura Biotechnology Co are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Inventory i.e., Maccura Biotechnology's Inventory and Total Liab go up and down completely randomly.

Correlation Coefficient

0.95

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Inventory

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Maccura Biotechnology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Maccura Biotechnology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Maccura Biotechnology Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

As of December 2, 2024, Selling General Administrative is expected to decline to about 478.8 M. In addition to that, Tax Provision is expected to decline to about 655.4 K

	2021	2022	2023	2024 (projected)
Operating Income	1.3B	894.9M	451.5M	651.0M
Total Revenue	4.0B	3.6B	2.9B	2.5B

Operating Income Total Revenue

Maccura Biotechnology fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Net Tangible Assets	Short Term Investments	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Non Current Assets Total	Non Currrent Assets Other
Total Assets		0.34	0.81	0.98	0.91	0.98	0.97	0.96	0.94	0.71	0.95	0.96	0.84	0.86	0.92	0.88	0.99	0.9	-0.14	0.94	0.86	0.46	0.98	0.94	0.95	-0.89
Other Current Liab	0.34		0.59	0.19	0.23	0.36	0.48	0.3	0.24	0.71	0.5	0.53	0.61	0.63	0.09	0.23	0.27	0.11	0.57	0.31	0.0	0.69	0.43	0.32	0.19	-0.39
Total Current Liabilities	0.81	0.59		0.67	0.73	0.75	0.86	0.79	0.79	0.75	0.94	0.91	0.9	0.99	0.71	0.79	0.75	0.54	0.03	0.84	0.71	0.86	0.83	0.9	0.67	-0.9
Total Stockholder Equity	0.98	0.19	0.67		0.88	0.97	0.92	0.92	0.9	0.6	0.87	0.89	0.74	0.73	0.92	0.86	0.98	0.95	-0.22	0.9	0.85	0.28	0.93	0.87	0.96	-0.8
Other Liab	0.91	0.23	0.73	0.88		0.93	0.91	0.91	0.99	0.75	0.85	0.89	0.69	0.8	0.96	0.72	0.89	0.85	-0.1	0.84	0.78	0.28	0.93	0.92	0.93	-0.79
Retained Earnings	0.98	0.36	0.75	0.97	0.93		0.96	0.95	0.94	0.76	0.92	0.95	0.78	0.82	0.92	0.82	0.98	0.93	-0.08	0.92	0.8	0.37	0.97	0.91	0.97	-0.84
Accounts Payable	0.97	0.48	0.86	0.92	0.91	0.96		0.95	0.94	0.78	0.96	0.98	0.85	0.91	0.89	0.83	0.95	0.85	-0.02	0.9	0.79	0.53	0.98	0.93	0.92	-0.87
Cash	0.96	0.3	0.79	0.92	0.91	0.95	0.95		0.93	0.71	0.89	0.92	0.72	0.84	0.9	0.81	0.96	0.9	-0.14	0.91	0.85	0.43	0.94	0.93	0.95	-0.87
Other Assets	0.94	0.24	0.79	0.9	0.99	0.94	0.94	0.93		0.75	0.9	0.92	0.76	0.84	0.98	0.8	0.91	0.85	-0.16	0.88	0.84	0.36	0.95	0.97	0.93	-0.86
Long Term Debt	0.71	0.71	0.75	0.6	0.75	0.76	0.78	0.71	0.75		0.79	0.84	0.77	0.83	0.64	0.57	0.65	0.51	0.26	0.66	0.47	0.52	0.77	0.75	0.64	-0.71
Net Receivables	0.95	0.5	0.94	0.87	0.85	0.92	0.96	0.89	0.9	0.79		0.99	0.94	0.96	0.86	0.89	0.91	0.75	-0.06	0.93	0.81	0.68	0.95	0.95	0.84	-0.94
Inventory	0.96	0.53	0.91	0.89	0.89	0.95	0.98	0.92	0.92	0.84	0.99		0.92	0.95	0.87	0.87	0.92	0.78	-0.05	0.91	0.8	0.62	0.96	0.95	0.87	-0.93
Other Current Assets	0.84	0.61	0.9	0.74	0.69	0.78	0.85	0.72	0.76	0.77	0.94	0.92		0.9	0.72	0.83	0.75	0.55	-0.05	0.78	0.68	0.74	0.84	0.85	0.66	-0.9
Total Liab	0.86	0.63	0.99	0.73	0.8	0.82	0.91	0.84	0.84	0.83	0.96	0.95	0.9		0.75	0.77	0.8	0.61	0.08	0.86	0.7	0.79	0.89	0.92	0.74	-0.91
Intangible Assets	0.92	0.09	0.71	0.92	0.96	0.92	0.89	0.9	0.98	0.64	0.86	0.87	0.72	0.75		0.81	0.91	0.87	-0.26	0.88	0.88	0.26	0.92	0.94	0.94	-0.83
Common Stock	0.88	0.23	0.79	0.86	0.72	0.82	0.83	0.81	0.8	0.57	0.89	0.87	0.83	0.77	0.81		0.87	0.72	-0.44	0.85	0.94	0.55	0.8	0.85	0.76	-0.87
Property Plant Equipment	0.99	0.27	0.75	0.98	0.89	0.98	0.95	0.96	0.91	0.65	0.91	0.92	0.75	0.8	0.91	0.87		0.95	-0.17	0.95	0.87	0.39	0.96	0.9	0.97	-0.85
Net Tangible Assets	0.9	0.11	0.54	0.95	0.85	0.93	0.85	0.9	0.85	0.51	0.75	0.78	0.55	0.61	0.87	0.72	0.95		-0.16	0.85	0.77	0.12	0.88	0.78	0.98	-0.68
Short Term Investments	-0.14	0.57	0.03	-0.22	-0.1	-0.08	-0.02	-0.14	-0.16	0.26	-0.06	-0.05	-0.05	0.08	-0.26	-0.44	-0.17	-0.16		-0.06	-0.54	0.14	-0.01	-0.15	-0.13	0.25
Deferred Long Term Liab	0.94	0.31	0.84	0.9	0.84	0.92	0.9	0.91	0.88	0.66	0.93	0.91	0.78	0.86	0.88	0.85	0.95	0.85	-0.06		0.84	0.55	0.93	0.93	0.91	-0.87
Long Term Investments	0.86	0.0	0.71	0.85	0.78	0.8	0.79	0.85	0.84	0.47	0.81	0.8	0.68	0.7	0.88	0.94	0.87	0.77	-0.54	0.84		0.39	0.78	0.86	0.81	-0.83
Short Long Term Debt	0.46	0.69	0.86	0.28	0.28	0.37	0.53	0.43	0.36	0.52	0.68	0.62	0.74	0.79	0.26	0.55	0.39	0.12	0.14	0.55	0.39		0.47	0.56	0.24	-0.68
Total Current Assets	0.98	0.43	0.83	0.93	0.93	0.97	0.98	0.94	0.95	0.77	0.95	0.96	0.84	0.89	0.92	0.8	0.96	0.88	-0.01	0.93	0.78	0.47		0.95	0.95	-0.88
Short Term Debt	0.94	0.32	0.9	0.87	0.92	0.91	0.93	0.93	0.97	0.75	0.95	0.95	0.85	0.92	0.94	0.85	0.9	0.78	-0.15	0.93	0.86	0.56	0.95		0.89	-0.94
Non Current Assets Total	0.95	0.19	0.67	0.96	0.93	0.97	0.92	0.95	0.93	0.64	0.84	0.87	0.66	0.74	0.94	0.76	0.97	0.98	-0.13	0.91	0.81	0.24	0.95	0.89		-0.79
Non Currrent Assets Other	-0.89	-0.39	-0.9	-0.8	-0.79	-0.84	-0.87	-0.87	-0.86	-0.71	-0.94	-0.93	-0.9	-0.91	-0.83	-0.87	-0.85	-0.68	0.25	-0.87	-0.83	-0.68	-0.88	-0.94	-0.79

Click cells to compare fundamentals

Maccura Biotechnology Account Relationship Matchups

Maccura Biotechnology fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	5.5B	6.4B	6.6B	8.2B	8.1B	5.4B
Other Current Liab	155.7M	255.0M	189.9M	171.5M	10.0M	9.5M
Total Current Liabilities	1.8B	1.8B	1.3B	1.1B	1.1B	1.1B
Total Stockholder Equity	3.1B	3.8B	4.3B	6.3B	6.4B	3.8B
Other Liab	149.8M	231.9M	270.7M	248.0M	285.2M	299.5M
Retained Earnings	2.2B	2.9B	3.6B	4.0B	3.8B	2.5B
Accounts Payable	261.6M	402.1M	317.4M	380.9M	365.8M	244.9M
Cash	443.9M	612.1M	637.2M	587.3M	836.0M	487.8M
Other Assets	225.8M	327.2M	336.5M	342.8M	394.3M	414.0M
Long Term Debt	200M	329.7M	424.1M	285.8M	162.5M	240.5M
Net Receivables	2.0B	2.0B	1.9B	2.1B	1.8B	1.6B
Inventory	851.7M	1.1B	1.1B	1.0B	907.5M	775.1M
Other Current Assets	208.7M	235.8M	195.8M	251.9M	112.6M	175.1M
Total Liab	2.2B	2.4B	2.0B	1.6B	1.5B	1.5B
Intangible Assets	210.7M	245.6M	280.8M	374.5M	420.8M	441.8M
Common Stock	557.7M	557.1M	556.5M	612.5M	704.3M	524.6M
Property Plant Equipment	1.6B	1.7B	2.0B	2.5B	2.9B	1.5B
Net Tangible Assets	3.0B	3.6B	4.1B	5.9B	6.8B	3.5B
Deferred Long Term Liab	113.6M	64.2M	95.5M	113.4M	130.4M	72.7M
Short Long Term Debt	1.2B	921.5M	530.6M	248.1M	144.6M	137.4M
Total Current Assets	3.5B	4.0B	3.9B	4.7B	4.2B	3.6B
Non Current Assets Total	2.0B	2.3B	2.7B	3.5B	3.9B	2.5B
Non Currrent Assets Other	7.0M	2.0M	2.8M	6.1M	3.7M	3.5M
Non Current Liabilities Total	349.8M	561.6M	712.0M	548.8M	387.2M	416.6M
Net Debt	752.1M	941.3M	639.2M	317.5M	285.7M	476.0M
Common Stock Shares Outstanding	557.7M	557.1M	556.5M	612.5M	704.3M	630.5M
Net Invested Capital	4.5B	5.0B	5.3B	6.8B	6.7B	5.6B
Net Working Capital	1.7B	2.2B	2.5B	3.6B	3.1B	2.6B
Capital Stock	557.7M	557.1M	556.5M	612.5M	704.3M	633.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Other Information on Investing in Maccura Stock

Balance Sheet is a snapshot of the financial position of Maccura Biotechnology at a specified time, usually calculated after every quarter, six months, or one year. Maccura Biotechnology Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Maccura Biotechnology and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Maccura currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Maccura Inventory vs Total Liab Analysis

Inventory vs Total Liab

Inventory vs Total Liab Correlation Analysis

Correlation Coefficient

Inventory

Total Liab

Maccura Biotechnology fundamental ratios Correlations

Maccura Biotechnology Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Maccura Biotechnology fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Maccura Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant Equipment	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Current Liabilities
Other Assets	+ 0.99	Other Liab
Inventory	+ 0.99	Net Receivables
Total Stockholder Equity	+ 0.98	Total Assets
Retained Earnings	+ 0.98	Total Assets

Non Currrent Assets Other	- 0.94	Short Term Debt
Non Currrent Assets Other	- 0.94	Net Receivables
Non Currrent Assets Other	- 0.93	Inventory
Non Currrent Assets Other	- 0.91	Total Liab
Non Currrent Assets Other	- 0.9	Other Current Assets
Non Currrent Assets Other	- 0.9	Total Current Liabilities